93% of gay and bisexual men living with HIV are accessing HIV treatment, but additional strategies are needed to engage low-income and non-white men. What are the key study findings? Despite a high prevalence of HIV among gbMSM (23.4%), a small proportion of HIV-positive study participants (18.6%) had unsuppressed viral load (≥200 copies/ml), which is […]
The BC-CfE is proud to announce that Dr. Robert Hogg, a Senior Scientist with the Centre, has been recognized by the HIV/AIDS community for his commitment to improving through research the lives of those living with HIV/AIDS. On Sunday, April 24, Positive Living honoured Dr. Hogg with an AccolAIDS award for his work.
Dr. Robert Hogg Honoured for Critical Research Read More »
As life expectancy for HIV-positive people rises, it is seen as chronic illness that is manageable Manulife has become the first Canadian insurance company to offer life insurance to people who are HIV-positive. In a release Friday, the insurance conglomerate said it made the decision after it reviewed the latest mortality and long-term survival rates
Manulife to offer life insurance to HIV-positive Canadians for 1st time Read More »
A Q&A with SFU assistant professor Angela Kaida Women living with HIV have high rates of sexual inactivity and dissatisfaction, and a lower quality of life. This is according to Angela Kaida, the Canada Research Chair in Sexual and Reproductive Health, and one of the women who is part of a research group studying stigma
SFU study explores stigma faced by HIV-positive women Read More »
Robert Hogg focuses on identifying ongoing health inequities among vulnerable HIV-positive populations to better meet their unique health care needs. Since the early 1990s, SFU professor of health sciences Dr. Robert Hogg has been conducting demographic research on British Columbia’s HIV-positive population. With an eye towards influencing health policy decisions and improving health outcomes, his
Stemming an Epidemic Read More »
An antiretroviral drug is showing promise in the fight to eliminate AIDS by drastically reducing the odds of contracting HIV when taken before and after sex. According to a new study published by the New England Journal of Medicine on World AIDS Day Tuesday, study participants who took the antiretroviral drug Truvada prior to, and
Drug nearly eliminates risk of HIV transmission when taken as needed Read More »
SFU study suggests that having HIB can be a risk factor for women to develop certain cancers A new study published by SFU researchers suggests that women who are living with HIV may be more likely to develop cancer. Published in HIV Medicine, the study shows that compared to the general population, women who have
Women with HIV at greater risk for cancer Read More »
Researcher says HIV-positive women in treatment program are more likely to be diagnosed with invasive cervical cancer. Woman living with HIV face elevated risk of certain cancers, a new British Columbia study has found. By comparing databases of the B.C. Cancer Agency and the B.C. Centre for Excellence in HIV/AIDS (BC-CfE), Simon Fraser University PhD
Women with HIV face higher rates of certain cancers: B.C. study Read More »
